AO 90
methionine deprived amino acid solution; no further information available 6/91
Networked: 11
relevant articles (3 outcomes,
5 trials/studies)
Relationship Network
Bio-Agent Context: Research Results
Experts
Related Diseases
1. | Stomach Neoplasms (Stomach Cancer)
06/01/1995
- " The results show that AO-90 improved the quality of life of patients with advanced recurrent gastric cancer." 05/01/1995
- " These results show that AO-90 in combination with MF therapy is efficacious in the treatment of patients with gastric cancer." 05/01/1995
- " Based on these results, AO-90 in the MF regimen appears to be effective in the treatment of patients with advanced gastric cancer by significantly potentiating the effects of 5-FU." 05/01/1995
- " In the present multi-center, randomized, controlled study conducted at the internal medicine departments of 24 institutions between July 1991 and May 1993, patients with advanced gastric cancer were randomly allocated to receive either AO-90 (500-750 mL/day, AO/MF group) or Amiparen, a commercial intravenous amino acid solution (600-800 mL/day, C/MF group) by total parenteral nutrition for 14 days. " 05/01/1995
- " In the present multi-center, randomized, controlled study conducted at the surgery departments of 53 institutions between July 1991 and March 1993, patients with advanced gastric cancer were randomly allocated to receive either AO-90 (500-750 mL/day, AO/MF group) or Amiparen, a commercial intravenous amino acid solution (600-800 mL/day, C/MF group) by total parenteral nutrition for 14 days. "
|
2. | Neoplasms (Cancer)
|
3. | Gastrointestinal Neoplasms (Gastrointestinal Cancer)
|
4. | Yoshida Sarcoma
|
5. | Shoulder Fractures
|
|
Related Drugs and Biologics
Related Therapies and Procedures